Endpoints News ١٥ ديسمبر ٢٠٢٥ Immunome's rare tumor drug passes Phase 3 test, could challenge Merck KGaA
Endpoints News ١٥ ديسمبر ٢٠٢٥ Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfront
Endpoints News ١٥ ديسمبر ٢٠٢٥ Western genetic medicine makers turn to Chinese investigator-initiated trials
Endpoints News ١٣ ديسمبر ٢٠٢٥ Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more
Endpoints News ١٢ ديسمبر ٢٠٢٥ 340B sales grew 23% last year, and court battle over pilot program intensifies
Endpoints News ١٢ ديسمبر ٢٠٢٥ Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say
Endpoints News ١٢ ديسمبر ٢٠٢٥ CHMP calls to reject Anavex's Alzheimer’s pill over impurities, side effects and weak efficacy
Endpoints News ١٢ ديسمبر ٢٠٢٥ #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
Endpoints News ١٢ ديسمبر ٢٠٢٥ Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor
Endpoints News ١٢ ديسمبر ٢٠٢٥ FDA broadens label for Amgen's Uplizna as it enters rare disease competition